These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25068979)

  • 1. Rare diseases. Foreword.
    Jones LH
    Future Med Chem; 2014 Jun; 6(9):969-70. PubMed ID: 25068979
    [No Abstract]   [Full Text] [Related]  

  • 2. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction and welcome message].
    Schwebig A; Levy N; Ayme S
    Presse Med; 2012 May; 41 Suppl 1():S1-2. PubMed ID: 22483772
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare-disease project has global ambitions.
    Abbott A
    Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare disease patient groups as clinical researchers.
    Polich GR
    Drug Discov Today; 2012 Feb; 17(3-4):167-72. PubMed ID: 22016088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 8. Solving for x: accelerators could speed search for rare disease therapies.
    Wolfson W
    Chem Biol; 2013 Dec; 20(12):1435-7. PubMed ID: 24359846
    [No Abstract]   [Full Text] [Related]  

  • 9. [Round table 1. PNMR 2011-2014: point of view of the stakeholders].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):8-13. PubMed ID: 24755171
    [No Abstract]   [Full Text] [Related]  

  • 10. 35 years of Japanese policy on rare diseases.
    Hayashi S; Umeda T
    Lancet; 2008 Sep; 372(9642):889-90. PubMed ID: 18790305
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.
    Bloom BE
    Contemp Clin Trials; 2011 Mar; 32(2):151-2. PubMed ID: 21238613
    [No Abstract]   [Full Text] [Related]  

  • 12. [GPs: patients require you to doubt! Interview by Catherine Holué].
    Viollet V
    Rev Prat; 2012 Jan; 62(1):85-6. PubMed ID: 22335075
    [No Abstract]   [Full Text] [Related]  

  • 13. Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem.
    Bakker AC; La Rosa S
    EMBO Mol Med; 2017 Sep; 9(9):1179-1182. PubMed ID: 28743783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Round table 3. How to improve French competitiveness in clinical research].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):28-32. PubMed ID: 24755176
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with rare diseases work to jump-start research; advocacy groups create their own tissue banks to aid in drug treatment.
    Marcus AD
    Wall St J (East Ed); 2006 Jul; ():D1, D2. PubMed ID: 16906687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings of the First International Symposium on Translational Clinical Research for Inherited and Orphan Retinal Diseases. November 5-7, 2004. Washington, DC, USA.
    Retina; 2005 Dec; 25(8 Suppl):S1-113. PubMed ID: 16509005
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards efficiency in rare disease research: what is distinctive and important?
    Jia J; Shi T
    Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Bespoke Gene Therapy Consortium' sets out to enable gene therapies for ultra-rare diseases.
    Kingwell K
    Nat Rev Drug Discov; 2021 Dec; 20(12):886-887. PubMed ID: 34773079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.